Edition:
United States

People: Ironwood Pharmaceuticals Inc (IRWD.O)

IRWD.O on Nasdaq

10.37USD
14 Jun 2019
Change (% chg)

-- (--)
Prev Close
$10.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,453,744
52-wk High
$21.20
52-wk Low
$9.07

Hecht, Peter 

Dr. Peter M. Hecht, Ph.D. is the Chief Executive Officer, Director of the Company. He has served as our chief executive officer and a director since our founding in 1998. Under his leadership, Ironwood has grown from nine Ph.D. scientists to a commercial biotechnology company. Prior to founding Ironwood, Dr. Hecht was a research fellow at Whitehead Institute for Biomedical Research. Dr. Hecht earned a B.S. in mathematics and an M.S. in biology from Stanford University, and holds a Ph.D. in molecular biology from the University of California at Berkeley.

Basic Compensation

Total Annual Compensation, USD 100,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 5,895,460
Fiscal Year Total, USD 5,995,460

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 300,790 2,762,470.00
Name Fiscal Year Total

Peter Hecht

5,995,460

Gina Consylman

967,516

Mark Currie

2,624,690

Thomas McCourt

2,309,340

Halley Gilbert

1,933,570

Jon Duane

--
As Of  30 Dec 2017